Jump to content

Jamshed Bomanji

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Tony1 (talk | contribs) at 00:36, 6 December 2020 (Script-assisted fixes: per MOS:NUM, MOS:CAPS, MOS:LINK). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jamshed Bomanji is a full professor, clinical lead, and head of the Institute of Nuclear medicine department at the University College Hospital (UCLH) NHS foundation trust based in London, UK.[1]

Education and career

Professor Bomaji obtained a graduate degree in 1980, and a PhD in 1987. His current interests are in the area of diagnostic and therapeutic of Neurology, Oncology, Cardiology, and Nephrology/Urology using Nuclear medicine.

Jamshed Bomanji also serves as the Editor-in-chief at the Nuclear Medicine Communications.[2] His comments on cancer procedures using nuclear medicine techniques are documented by Hospitals[3] and private companies.[4][5][6]

Books

Jamshed has authored 20 book Chapters.[1] Some of them are in the areas including, not limited to, Neuroendocrine Tumours,[7] Tissue Characterization,[8] Molecular radiotherapy in Children,[9] and Brain Disorder.[10] He has an edited book titled "A History of Radionuclide Studies in the UK: 50th Anniversary of the British Nuclear Medicine".[11]

Publications

He has published more than 270 scientific Manuscripts, with over 6000 Citations.[12] His manuscript titled "Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐D Phe1,Tyr3‐octreotate) and 18F‐FDG" published in 2008 has been cited more than 300 times alone. He published his first research paper in 1984 titled "123 I meta-iodo-benzyl guanidine: Synthesis and imaging the adrenal medulla and phaeochromocytoma" in the Journal of Nuclear Medicine in Research and Practice.

References

  1. ^ a b "UCLH website".{{cite web}}: CS1 maint: url-status (link)
  2. ^ "LWW website".{{cite web}}: CS1 maint: url-status (link)
  3. ^ "UCLH News".{{cite web}}: CS1 maint: url-status (link)
  4. ^ "Prnewswire website".{{cite web}}: CS1 maint: url-status (link)
  5. ^ "Biospace website".{{cite web}}: CS1 maint: url-status (link)
  6. ^ "Eurekalert website".{{cite web}}: CS1 maint: url-status (link)
  7. ^ Hoskin, Peter J. (2007). Radiotherapy in practice : radioisotope therapy. Oxford University Press. ISBN 978-0-19-176878-1. OCLC 906032566.
  8. ^ Bomanji, Jamshed. (1987). Tissue characterization : using 123ı-metaiobenzylguanidine and 99m Tc monoclonal antibody (223.28s) fragments. University of London. OCLC 17924070.
  9. ^ Mansi, Luigi, Herausgeber. Lopci, Egesta, Herausgeber. Cuccurullo, Vincenzo, Herausgeber. Chiti, Arturo, Herausgeber. Clinical Nuclear Medicine in Pediatrics. ISBN 978-3-319-21371-2. OCLC 941397753.{{cite book}}: CS1 maint: multiple names: authors list (link)
  10. ^ Fraioli, Francesco Herausgeber. PET/CT in Brain Disorders. ISBN 978-3-030-01523-7. OCLC 1091713200.
  11. ^ McCready, Ralph. Gnanasegaran, Gopinath. Bomanji, Jamshed B. (2016). A History of Radionuclide Studies in the UK 50th Anniversary of the British Nuclear Medicine Society. Springer International Publishing. ISBN 978-3-319-28624-2. OCLC 955942471.{{cite book}}: CS1 maint: multiple names: authors list (link)
  12. ^ "Scopus website".{{cite web}}: CS1 maint: url-status (link)